Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo (Q34044910)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q37830565)
(P304) 492-500
(P433) 2
(P478) 30
(P577) Tuesday, September 15, 2015
(P1433) (Q6534498)
(P1476) "Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo" (language: en)
(P2093) D Sommermeyer
P L Kosasih
T Gogishvili
D G Maloney
C J Turtle
S R Riddell
(P2860) (Q40186710)
(Q29617588)
(Q36408432)
(Q34041792)
(Q42205546)
(Q29617590)
(Q38170500)
(Q37004749)
(Q37244349)
(Q38094968)
(Q29620130)
(Q36654128)
(Q28730418)
(Q29620717)
(Q35651760)
(Q28248395)
(Q29622949)
(Q24632975)
(Q24594920)
(Q35153765)
(Q34876434)
(Q34667739)
(Q34625160)
(Q34374056)
(Q37389018)
(Q24651232)
(Q37117781)
(Q36979111)
(Q40003380)
(Q36183567)
(Q40395714)
(Q24530100)
(Q35768856)
(Q41750120)
(Q44758058)
(Q44525218)
(Q42938990)
(Q51968727)
(Q50850469)
(Q50085632)
(Q45984095)
(Q52008481)
(Q45741637)
(Q54226572)
(Q67714030)
(Q72356532)
(Q73821475)
other details
description scientific article

External Links